top of page
Writer's picturefxmethods

WESNESDAY : - USDINR NEAR SUPPORT , DOLLAR WEAKER !!

USDINR likely to commence trading on Wednesday session with in mild weakness as greenback subdued on surging cases have driven record hospitalizations and fresh restrictions on gathering in the United States, while new outbreaks vex authorities in Japan, South Korea and Australia.

  • Yesterday , USDINR opened at 74.45 then corrected for some extent till 74.3650/3750 levels, from there pair got nice bidding till 74.6425/6525 levels before settled at 74.4450/4550.

  • India hopes five locally-tested vaccines will help it to control COVID-19, as those developed by Pfizer and Moderna may not be available to it in big quantities soon.

  • India and China may start producing Russia's Sputnik V vaccine against COVID-19, the RIA news agency cited President Vladimir Putin as saying on Tuesday.

  • Lakshmi Vilas Bank is set to be folded into the Indian unit of Singapore's DBS under a plan proposed by the Reserve Bank of India (RBI), which took over LVB on Tuesday due to a "serious deterioration" in its finances.


INTRADAY RANGE - 74.05 ( 74.33 - 74.62 ) 74.85



GLOBAL HIGHLIGHTS

Britain's chief negotiator David Frost has told Prime Minister Boris Johnson to expect a Brussels trade deal "early next week", The Sun newspaper reported, with "a possible landing zone" as soon as next Tuesday.


The safe-haven Japanese yen sat near a one-week high and a steady U.S. dollar held commodity currencies in check, as worries about rising coronavirus cases tempered optimism around promising vaccine trials.


President-elect Joe Biden's top coronavirus advisers warned on Tuesday that President Donald Trump's stalling of the transition could hinder the country's pandemic response, as Trump and his allies persisted in challenging the Nov. 3 election results.


Brazil's Sao Paulo state is set to begin importing the first of 46 million doses of China's Sinovac vaccine against COVID-19 this week, while the federal government takes a more cautious approach with a vaccine developed by Pfizer Inc.


France on Tuesday became the first European country to surpass 2 million coronavirus cases despite an Oct. 30 nationwide lockdown that has led to a sharp decline in new infections, according to a Reuters tally.

9 views0 comments

Comments


bottom of page